6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
ID: 36C77025Q0047Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b010ff527e2c4f8b86afb4ab92b05a21/view
Timeline
    Description

    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    (913) 684-0140
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77025Q0047_1.docx
    The document outlines a government Request for Proposal (RFP) from the Department of Veterans Affairs for the procurement of a pharmaceutical product, specifically Dorzolamide/Timolol solution. The key aspects include the solicitation details, set aside percentages for small businesses, and stipulations for product delivery, quality standards, and invoicing procedures. Offerors are required to provide comprehensive documentation including pricing, National Drug Codes (NDCs), and compliance with the Trade Agreements Act. The RFP emphasizes adherence to stringent pharmaceutical standards, including barcoding and therapeutic equivalence. Additionally, contractors must ensure compliance with supply chain security regulations and provide reliable tracking information during shipment. The document further stipulates the need for completion of various forms and clauses per Federal Acquisition Regulation (FAR) guidelines, focusing on electronic payment processes and requirements for invoice submission. This procurement effort reflects the VA's commitment to delivering high-quality medical products to veterans, while ensuring procurement integrity and adherence to federal guidelines.
    36C77025Q0047.docx
    The Department of Veterans Affairs, Network Contracting Office 15, intends to procure DORZOLAMIDE/TIMOLOL ophthalmic solution across multiple Centralized Mail Order Pharmacy (CMOP) facilities. The presolicitation notice highlights items needed for different locations, including quantities ranging from 2,880 to 9,600 units of 10ML packaging. The solicitation (No. 36C77025Q0047) is set aside for full and open competition, with a goal to obtain submissions by November 12, 2024, following a release date of November 4, 2024. Vendors must comply with the Drug Supply Chain Security Act and provide their state wholesale distributor license, along with a signed solicitation cover page and a trade agreements certificate with their quotations. The delivery timeframe for the orders is set to 10 days after receipt of the order. This notice provides essential contact information for the contracting office and emphasizes responsibility for interested parties to monitor changes via SAM.GOV. The document underscores the VA’s commitment to supplying necessary pharmaceuticals to its facilities effectively and efficiently.
    S02_Pricing Schedule_Q0047.xlsx
    The file outlines a Request for Quotations (RFQ) from the CMOP (Centralized Medical Order Processing) for the procurement of specific pharmaceuticals, particularly DORZOLAMIDE 22.3/TIMOLOL6.8MG/ML Ophthalmic Solution. The RFQ, identified as 36C77025Q0047, includes a timeline for submission, with a posting date of November 4, 2024, and a closing date of November 12, 2024, at 3:00 PM Central Time. Vendors are required to submit several documents, including a signed SF1449 form, a quote spreadsheet, a valid State Wholesale Distributor License, and a Trade Agreement Act Certificate. The document specifies the unit prices, quantities, and total price for various line items, emphasizing the need for TAA compliance and that expiration dates for products must be at least one year from the delivery date. It also directs submissions to Kelley Cunningham at the provided email. Ultimately, this RFQ serves as part of the federal procurement process aimed at ensuring the acquisition of necessary medical supplies while adhering to regulatory standards and compliance requirements.
    Similar Opportunities
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77025Q0050 760-25-1-050-0022 - Leavenworth CMOP AMLODIPINE (VA-25-00014183)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) facility in Leavenworth, Kansas, under solicitation number 36C77025Q0050. The procurement includes a range of medications, with specific quantities and packaging requirements, emphasizing compliance with the Drug Supply Chain Security Act and the Buy American statute. This initiative is crucial for ensuring a reliable supply of essential medications for veteran care services. Interested vendors must submit their quotes, including a signed SF1449 cover page, a price schedule in Excel format, and a state wholesale distributor license, by November 6, 2024, with an anticipated award date of November 13, 2024. For further inquiries, vendors can contact Jeffrey Blackard at Jeffrey.Blackard@va.gov or (913) 684-0142.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    6505--770-25-1-801-0019 -National CMOP BUDESONIDE -(VA-25-00010963)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Budesonide 0.5MG/2ML inhalation suspension through the National CMOP program. Vendors are required to submit a signed SF1449 solicitation cover page, a completed quote spreadsheet, evidence of a valid state wholesale distributor license, and a Trade Agreement Act certificate, with all submissions due by November 8, 2024. This pharmaceutical is critical for the treatment of respiratory conditions among veterans, and all products must comply with stringent regulatory standards, including bar-coding and adherence to the Drug Supply Chain Security Act. Interested vendors can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further details.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0052 770-25-1-801-0071 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking bids for an emergency procurement of Ferrous Sulfate 324MG EC Tablets, specifically packaged in bottles of 100, to be delivered to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the United States. The procurement requires a total of seven different quantities ranging from 1,200 to 9,600 units, with a delivery timeframe of 10 days after receipt of order (ARO). This initiative is crucial for maintaining a reliable pharmaceutical supply chain to support the healthcare needs of veterans. Interested vendors must submit their proposals by November 6, 2024, at 9:00 AM CST, including a signed SF1449 cover page, a price schedule in Excel format, a state wholesale distributor license, and a completed Trade Agreements Certificate, with the estimated award date set for November 12, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--Verapamil Hydrochloride (HCL) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules, aimed at supporting various health service agencies, including the VA, Bureau of Prisons, and others. This unrestricted procurement will award one contract per group, with a total contract duration of one year and the potential for four additional one-year option periods. The procurement is critical for ensuring a reliable supply of essential medications, with specific packaging requirements including safety caps and unique NDC numbers for the products. Interested offerors should note that the solicitation is expected to be released electronically on or around November 19, 2024, with a closing date of December 3, 2024. For further inquiries, interested parties can contact Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Calcitonin Gene-Related Peptides (CGRP) through its Pharmaceutical Prime Vendor (PPV) Program. This procurement aims to establish a contract that ensures a consistent supply of these pharmaceutical products while adhering to federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). The CGRP products are critical for various medical treatments within VA facilities, emphasizing the importance of quality control and reliable delivery. Interested offerors must submit their proposals by November 7, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.